Journals speed up flu studies

Many top tier science journals are going into overdrive to publish data about the emerging swine-origin influenza A (H1N1) virus epidemic, compressing what is often a multi-month process into just a few days or weeks. Influenza virusImage: National High Magnetic Field Laboratory,Florida State UniversityAn international research team led by linkurl:Neil Ferguson;http://www1.imperial.ac.uk/medicine/people/neil.ferguson/ of Imperial College London published a linkurl:report;http://www.sciencemag.

Written byElie Dolgin
| 2 min read

Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share
Many top tier science journals are going into overdrive to publish data about the emerging swine-origin influenza A (H1N1) virus epidemic, compressing what is often a multi-month process into just a few days or weeks.
Influenza virus
Image: National High Magnetic Field Laboratory,
Florida State University
An international research team led by linkurl:Neil Ferguson;http://www1.imperial.ac.uk/medicine/people/neil.ferguson/ of Imperial College London published a linkurl:report;http://www.sciencemag.org/cgi/content/abstract/1176062 online today (May 11) in __Science__ showing that the current outbreak is on par or less hazardous than previous influenza pandemics. The researchers analyzed data from late April and found that the virus' transmission rate and clinical severity are not as bad as seen during the 1918 Spanish flu but are similar to other 20th century pandemics. Although the study was received and published in less than a week, "the paper was subjected to usual standards during the rigorous review process," linkurl:Natasha Pinol,;http://www.aaas.org/news/media_contacts/ a __Science__ spokesperson, said in an email. Last Thursday (May 7), a team of epidemiologists from US Centers for Disease Control and Prevention published a linkurl:study;http://content.nejm.org/cgi/content/full/NEJMoa0903810 in the __New England Journal of Medicine__ (NEJM) chronicling all 642 reported cases of human infection with the virus dating from April 15 to May 5. This analysis detailed the most common symptoms of the disease and showed that young people might be particularly susceptible to infection. "We knew this was important and we wanted to get it out," linkurl:Edward Campion,;http://content.nejm.org/misc/edboard.shtml __NEJM__'s senior deputy editor and online editor, told __The Scientist__. The paper underwent a full peer review process, but each review "was compressed into a day or two." Campion noted that the 2003 outbreak of Severe Acute Respiratory Syndrome (SARS) prepared __NEJM__ for the latest epidemic. This time around, the journal could respond even quicker, though, because its updated electronic review system streamlined and accelerated the publication pipeline. "The limiting factor is the human effort," he noted. __NEJM__ editors "worked overtime, evening and weekends" to get the paper ready for publication. "It's a very demanding process, and something we save for those few times a year when we really need it," he said. The open access publisher __BioMed Central__ (BMC) -- which will be publishing many original articles, commentaries, editorials and mini-reviews relating to the latest H1N1 virus within the coming weeks -- is "working hard to process all flu-related manuscripts as rapidly as we can," said linkurl:Melissa Norton,;http://www.biomedcentral.com/info/about/whoweare __BMC__'s editorial director of Medicine. Reviewers, editors, and authors alike are asked to handle manuscripts in an expedited fashion, which allows papers to be published within "a matter of weeks," she said.
**__Related stories:__***linkurl:What about fast-track?;http://www.the-scientist.com/article/display/23063/
[February 2006]*linkurl:Speed the publishing process;http://www.the-scientist.com/article/display/16398/
[20th February 1995]
Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Meet the Author

Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies